• Mashup Score: 1

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • Online—Hyperglycaemia management in non-critical care settings: guidelines in focus https://t.co/MQNF3UM79D #hyperglycaemia #diabetes #hospital https://t.co/hvztBEfOWs

  • Mashup Score: 4

    Hyperglycaemia in people with and without diabetes admitted to the hospital is associated with a substantial increase in morbidity, mortality, and health-care costs. Professional societies have recommended insulin therapy as the cornerstone of inpatient pharmacological management. Intravenous insulin therapy is the treatment of choice in the critical care setting. In non-intensive care settings,…

    Tweet Tweets with this article
    • Management of #diabetes and #hyperglycaemia in the #hospital https://t.co/qlfviBRfJa #T1D #T2D #inpatient #insulin #COVID19 #FREE to read https://t.co/6wFFhyQ283

  • Mashup Score: 1

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • Online—Hyperglycaemia management in non-critical care settings: guidelines in focus https://t.co/MQNF3UM79D #hyperglycaemia https://t.co/oDaBqNAzOZ

  • Mashup Score: 12

    The Endocrine Society recently published an update to their guideline, Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings,1 10 years after the initial publication.2 Much has happened over the past decade in the diabetes arena, including the availability of new classes of medications such as SGLT2 inhibitors, long-acting GLP-1 receptor agonists, and shorter-acting…

    Tweet Tweets with this article
    • New—Hyperglycaemia management in non-critical care settings: guidelines in focus https://t.co/MQNF3UM79D #hyperglycaemia https://t.co/EtCi2r1WRb

  • Mashup Score: 2

    The Americas comprise regions that are enormously diverse both culturally and socioeconomically; thus, disease burdens tend to differ country to country. In The Lancet Diabetes & Endocrinology, using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, the GBD 2019 Diabetes in the Americas Collaborators demonstrate the high heterogeneity of the burden of both type…

    Tweet Tweets with this article
    • Also read the Linked Comment: The burden of #diabetes in the #Americas https://t.co/VlwagfDEJI #hyperglycaemia https://t.co/M11eCZnBWt

  • Mashup Score: 11

    Hyperglycaemia in people with and without diabetes admitted to the hospital is associated with a substantial increase in morbidity, mortality, and health-care costs. Professional societies have recommended insulin therapy as the cornerstone of inpatient pharmacological management. Intravenous insulin therapy is the treatment of choice in the critical care setting. In non-intensive care settings,…

    Tweet Tweets with this article
    • In our #MostRead: Management of #diabetes and #hyperglycaemia in the #hospital https://t.co/qlfviBRfJa #T1D #T2D #insulin #COVID19 #FREE to read https://t.co/6KrEGD7KoK